Identification of EML4-ALK Rearrangement and MET Exon 14 R988C Mutation in a Patient With High-Grade Neuroendocrine Lung Carcinoma Who Experienced a Lazarus Response to Crizotinib
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.05.035
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2018
Authors
Publisher
Elsevier BV